                               SEQUENCE LISTING

<110> SANGAMO BIOSCIENCES, INC.
 
<120> METHODS AND COMPOSITIONS FOR ENGINEERING IMMUNITY

<130> 8325-0146.40

<140> PCT/US2016/063146
<141> 2016-11-21

<150> 62/405,521
<151> 2016-10-07

<150> 62/258,864
<151> 2015-11-23

<160> 27    

<170> PatentIn version 3.5

<210> 1
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Arg Ser Asp Asn Leu Ser Glu 
1               5           


<210> 2
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Gln Ser Gly Asn Leu Ala Arg 
1               5           


<210> 3
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Asp Arg Ser Asn Leu Ser Arg 
1               5           


<210> 4
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Trp Arg Ser Ser Leu Arg Ala 
1               5           


<210> 5
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Asp Ser Ser Asp Arg Lys Lys 
1               5           


<210> 6
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Thr Ser Gly Ser Leu Thr Arg 
1               5           


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Arg Ser Asp Ala Leu Ser Thr 
1               5           


<210> 8
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Gln Ser Ala Thr Arg Thr Lys 
1               5           


<210> 9
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Leu Arg His His Leu Thr Arg 
1               5           


<210> 10
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Gln Ala Gly Gln Arg Arg Val 
1               5           


<210> 11
<211> 28
<212> DNA
<213> Mus sp.

<400> 11
tttcctgtaa cgatcgggaa ctggcatc                                          28


<210> 12
<211> 28
<212> DNA
<213> Mus sp.

<400> 12
ctgaaggtgg caatggttcc tctctgct                                          28


<210> 13
<211> 23
<212> DNA
<213> Homo sapiens

<400> 13
taattttctt ttgcgcacta agg                                               23


<210> 14
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 14
gtaattttct tttgcgcact a                                                 21


<210> 15
<211> 23
<212> DNA
<213> Homo sapiens

<400> 15
tgactgaaac ttcacagaat agg                                               23


<210> 16
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 16
gtgactgaaa cttcacagaa t                                                 21


<210> 17
<211> 23
<212> DNA
<213> Homo sapiens

<400> 17
gactgaaact tcacagaata ggg                                               23


<210> 18
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 18
gactgaaact tcacagaata                                                   20


<210> 19
<211> 23
<212> DNA
<213> Homo sapiens

<400> 19
tagtgcaatg gataggtctt tgg                                               23


<210> 20
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 20
gtagtgcaat ggataggtct t                                                 21


<210> 21
<211> 23
<212> DNA
<213> Homo sapiens

<400> 21
taaagcatag tgcaatggat agg                                               23


<210> 22
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 22
gtaaagcata gtgcaatgga t                                                 21


<210> 23
<211> 23
<212> DNA
<213> Homo sapiens

<400> 23
gatcaacagc acaggttttg tgg                                               23


<210> 24
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 24
gatcaacagc acaggttttg                                                   20


<210> 25
<211> 117
<212> DNA
<213> Homo sapiens

<400> 25
tcatctgtca ttgatgcact gcagtacaaa ttagagggca ccacaagatt gacaagaaaa       60

aggggattga agttagccac agctctgtct ctgagcaaca aatttgtgga gggtagt         117


<210> 26
<211> 39
<212> PRT
<213> Homo sapiens

<400> 26
Ser Ser Val Ile Asp Ala Leu Gln Tyr Lys Leu Glu Gly Thr Thr Arg 
1               5                   10                  15      


Leu Thr Arg Lys Arg Gly Leu Lys Leu Ala Thr Ala Leu Ser Leu Ser 
            20                  25                  30          


Asn Lys Phe Val Glu Gly Ser 
        35                  


<210> 27
<211> 9
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: Naturally-occurring meganuclease
      peptide

<400> 27
Leu Ala Gly Leu Ile Asp Ala Asp Gly 
1               5                   

